ICD-10 Code R22.2: Localized Swelling, Mass and Lump, Trunk – Complete Coding & Billing Guide

What Does ICD-10 Code R22.2 Mean?

ICD-10 code R22.2 — Localized swelling, mass and lump, trunk — is a billable diagnosis code used when a patient presents with a discrete, palpable swelling, mass, or lump involving the trunk of the body (chest wall, back, abdomen, flank, or groin) and no definitive underlying diagnosis has yet been established. It belongs to Chapter 18: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified, under category R22 (Localized swelling, mass and lump of skin and subcutaneous tissue).

Key attributes at a glance:

• Valid and billable for FY2026 (October 1, 2025 – September 30, 2026) per CMS ICD-10-CM Official Coding Guidelines
• Symptom code — appropriate only when no definitive diagnosis is documented
• Applicable settings: outpatient, ED, and inpatient (with sequencing restrictions)
• Electronic filing: submit as R222 (no decimal point) to prevent claim rejection

What Conditions and Diagnoses Does R22.2 Cover?

R22.2 captures any clinically observed, localized soft-tissue mass or swelling of the trunk that has not been given a confirmed etiology. Common clinical presentations coded here include:

• Undiagnosed subcutaneous nodule of the chest wall, back, or abdominal wall
• Unexplained lump of the flank or groin region (non-inguinal hernia presentation)
• Soft-tissue swelling following trauma, before imaging confirms or rules out deeper injury
• Male breast mass where N63 series (female-specific) is inapplicable and no definitive male breast diagnosis is established
• Bony prominence or swelling of the thoracic or lumbar spine region (before imaging workup)
• Anterior mediastinal mass identified clinically but not yet confirmed by pathology

What Does R22.2 Specifically Exclude?

The tabular entry carries both Type 1 (Excludes1) and Type 2 (Excludes2) notes that coders must honor. These conditions cannot be reported simultaneously with R22.2 (Excludes1 — mutually exclusive):

• Intra-abdominal or pelvic mass and lump (R19.0-) — internal organ-based masses, not skin/subcutaneous
• Intra-abdominal or pelvic swelling (R19.0-) — same distinction; location is interior, not wall-based
• Abnormal findings on diagnostic imaging (R90–R93) — imaging-detected incidentalomas use a different chapter
• Edema (R60.-) — diffuse fluid accumulation is distinct from a discrete localized mass
• Enlarged lymph nodes (R59.-) — lymphadenopathy has its own code family
• Localized adiposity (E65) — classified under endocrine/metabolic chapter
• Swelling of joint (M25.4-) — joint-space swelling is a musculoskeletal finding

When Is R22.2 the Right Code to Use?

R22.2 is a symptom code, which means it follows a strict selection logic. Use it only when all of the following criteria are met:

1. The patient has a palpable, discrete, localized mass or swelling on the trunk (chest wall, abdominal wall, back, flank, or groin)
2. The mass involves the skin or subcutaneous tissue layer — not an internal organ
3. No definitive diagnosis has been documented by the treating provider at the time of the encounter
4. The presenting finding is not better described by an existing specific code (lipoma, cyst, hernia, neoplasm, etc.)
5. For inpatient encounters, R22.2 is used as a secondary code only once a principal diagnosis is established; the symptom code is omitted if it is integral to a confirmed condition

How Does R22.2 Differ From R19.0x, M79.3, and Abdominal Hernia Codes?

In practice, the single most common sequencing error is retaining R22.2 on a follow-up claim after pathology has returned a confirmed diagnosis. Once results are finalized, R22.2 must be replaced by the definitive code.

What Documentation Is Required to Support R22.2?

What Must the Provider Document in the Clinical Notes?

For R22.2 to survive coding audit preparation and support medical billing documentation requirements, the clinical record must contain:

1. Physical examination findings specifically describing the mass — location on trunk, approximate size, texture (soft, firm, mobile, fixed), and surface characteristics
2. Clinical impression stating the finding is localized to skin or subcutaneous tissue (vs. internal organ)
3. Absence of confirmed diagnosis — the note must not contain a definitive pathological or radiological diagnosis for the mass
4. A plan for workup — imaging order, biopsy referral, or watchful waiting rationale that supports ongoing use of the symptom code
5. Provider signature and credentials on the note (standard authentication per ICD-10-CM Official Coding Guidelines Section IV.K for outpatient encounters)

Which Diagnostic or Lab Findings Support This Code?

R22.2 is appropriate before or pending results from:

• Ultrasound of soft-tissue mass (CPT 76882 — limited extremity/trunk ultrasound)
• CT of the chest, abdomen, or pelvis without contrast
• MRI of soft tissue
• Fine needle aspiration (FNA) cytology pending pathology report
• Excisional biopsy with pathology pending

Once results return a definitive diagnosis, R22.2 is retired in favor of the condition-specific code per ICD-10-CM Official Coding Guidelines Section I.C.18.

What Is the Documentation Standard for Inpatient vs. Outpatient Settings?

How Does R22.2 Affect Medical Billing and Claims?

Because R22.2 is a symptom code, payer scrutiny is higher than for definitive diagnosis codes. Key billing considerations include:

• Medical necessity must be clearly supported — payers want evidence the workup or procedure being billed is warranted for an undiagnosed trunk mass
• Symptom coding is acceptable on first-encounter or diagnostic claims; payers may flag R22.2 on repeat visits without documented progression of the workup
• R22.2 may be used as secondary diagnosis alongside a procedure code when the mass is the indication for the procedure
• Medicare and commercial payers generally cover imaging and FNA biopsy with R22.2 as the primary indication, but coverage is subject to LCD (Local Coverage Determination) review — verify with your MAC
• Do not report R22.2 with a neoplasm code or a confirmed pathology code on the same claim date

What CPT or Procedure Codes Are Commonly Billed With R22.2?

Are There Any Prior Authorization or Coverage Restrictions?

• Imaging: Most MACs and commercial payers cover trunk ultrasound and CT with R22.2 as an indication, but documentation of clinical findings is required — a bare R22.2 code without provider notes may trigger a records request
• Surgical excision: Prior auth is often required for excision of a benign-appearing mass; payers look for documented size, symptom burden, and failed conservative management
• Observation stays: R22.2 alone is unlikely to justify an inpatient admission; a more specific condition driving the workup should serve as the principal diagnosis

What Coding Errors Should You Avoid With R22.2?

These are the most commonly audited coding patterns involving R22.2:

1. Retaining R22.2 after a definitive diagnosis is established — the most frequent error; once pathology or imaging confirms a specific condition, the symptom code must be replaced
2. Using R22.2 for internal masses — intra-abdominal organ masses belong to the R19.0 series, not R22.2
3. Assigning R22.2 for lymphadenopathy — enlarged lymph nodes in the axillary, inguinal, or mediastinal regions are coded R59.x, not R22.2
4. Using R22.2 as principal diagnosis for inpatient claims when a more definitive diagnosis was established during the stay — violates ICD-10-CM guideline Section II for inpatient principal diagnosis selection
5. Omitting the decimal point awareness when switching between paper and electronic filing — electronic claims require R222 (no period); paper superbills use R22.2
6. Coding edema as R22.2 — diffuse or pitting edema of the trunk should be coded R60.x; R22.2 is reserved for discrete, localized masses

What Do Auditors Look for When Reviewing Claims With R22.2?

Auditors and coders conducting revenue cycle compliance reviews flag these patterns:

• R22.2 billed on multiple consecutive dates of service without documented workup progression
• Surgical procedure (e.g., excision) billed with R22.2 when pathology report in the same record confirms a definitive diagnosis — indicates delayed code update
• R22.2 paired with a neoplasm code when the mass is the presumed neoplasm (prior to confirmation)
• Physical exam documentation that is vague or missing anatomical specificity (e.g., “lump on body” without trunk location specified)

How Does R22.2 Relate to Other ICD-10 Codes?

Understanding R22.2 within the ICD-10-CM code family is essential for diagnosis code specificity and correct claim sequencing.

What Is the Correct Code Sequencing When R22.2 Appears With Other Diagnoses?

1. Outpatient, diagnostic encounter: R22.2 may be the first-listed diagnosis when it is the reason for the visit and no definitive diagnosis exists
2. Outpatient, procedure encounter (e.g., FNA): R22.2 serves as the indication diagnosis linked to the procedure code
3. Inpatient encounter with confirmed diagnosis at discharge: Replace R22.2 with the definitive code as principal diagnosis; do not retain R22.2 as a secondary if it is integral to the principal diagnosis
4. Inpatient encounter with inconclusive workup: R22.2 may remain as principal diagnosis only if no definitive cause was established after full workup per ICD-10-CM guideline Section II.H

Real-World Coding Scenario — How R22.2 Is Applied in Practice

Encounter Summary: A 54-year-old male presents to his primary care provider with a two-week history of a soft, non-tender lump on his right upper back. Physical exam reveals a 2.5 cm mobile subcutaneous mass. The provider documents “subcutaneous mass, right upper back — etiology undetermined, ultrasound ordered.” No definitive diagnosis is made at this visit.

Correct Code Application

• Primary diagnosis code: R22.2 — Localized swelling, mass and lump, trunk
• Rationale: The mass is located on the trunk (upper back), involves subcutaneous tissue, and has no confirmed etiology at the time of the encounter
• Procedure code linked: CPT 76882 for soft-tissue ultrasound of the trunk, with R22.2 as the supporting diagnosis

Common Mistake in This Scenario

• Incorrect code: R19.09 (intra-abdominal mass, unspecified site)
• Why it fails: R19.0x applies to internal abdominal contents, not the posterior trunk wall. The provider’s note clearly documents a subcutaneous mass — this is an Excludes1 violation if R19.0x is applied
• Second common error: If the ultrasound returns “consistent with lipoma,” and the follow-up claim still carries R22.2 — this is a documentation lag error. The coder should verify provider attestation and update to D17.1 (benign lipomatous neoplasm, trunk) for all dates of service after the confirmed finding is documented

Frequently Asked Questions About ICD-10 Code R22.2

Is ICD-10 Code R22.2 Still Valid for Use in FY2026?

ICD-10 code R22.2 remains a valid, billable diagnosis code for fiscal year 2026, effective October 1, 2025 through September 30, 2026, with no changes to its description or validity status. Coders should verify the code annually against the CMS ICD-10-CM Official Coding Guidelines release to confirm continued applicability.

What Is the Difference Between R22.2 and R19.0x?

R22.2 applies to masses involving the skin and subcutaneous tissue of the trunk — specifically the body wall. R19.0x (intra-abdominal or pelvic mass) applies to internal findings involving organs or intra-cavity structures. These two codes carry an Excludes1 relationship and must never be used simultaneously for the same mass.

Can R22.2 Be Used as a Principal Diagnosis for Inpatient Claims?

R22.2 may be used as principal diagnosis for an inpatient admission only when no more definitive underlying cause was established after a complete inpatient workup, per ICD-10-CM Official Coding Guidelines Section II.H. If the inpatient stay results in a confirmed diagnosis, that definitive code becomes principal and R22.2 is omitted.

What Code Replaces R22.2 After Pathology Confirms a Lipoma?

Once pathology confirms a benign lipoma of the trunk, the correct replacement code is D17.1 (benign lipomatous neoplasm of skin and subcutaneous tissue of trunk). R22.2 is a provisional symptom code and must be retired as soon as a definitive diagnosis is documented by the treating provider.

How Do I Code a Male Breast Mass Using R22.2?

When a male patient presents with an undiagnosed breast mass, R22.2 is the correct code because the N63 series (unspecified lump in breast) is gender-specific to female breast tissue in ICD-10-CM convention. If the mass is confirmed as gynecomastia, use N62; if a definitive neoplasm is identified, transition to the appropriate neoplasm code.

Should R22.2 Include a Decimal Point on Electronic Claims?

No. When submitting HIPAA-covered electronic claims, the decimal point must be omitted — submit the code as R222, not R22.2. Including the period in electronic transactions may trigger a rejection depending on the clearinghouse or payer system. Paper-based superbills and records use the standard formatted version R22.2.

What Documentation Is the Minimum Needed to Support R22.2 in an Audit?

At minimum, the medical record must contain a provider-documented physical examination finding describing a discrete, palpable mass located on the trunk, a clinical impression that no definitive diagnosis has been established, and a documented plan for further evaluation. A vague note stating only “mass” without anatomical location or clinical detail will likely fail coding audit preparation review.

Key Takeaways

• R22.2 is a billable symptom code — valid only when no definitive diagnosis has been established for a trunk mass
• The “trunk” anatomical scope includes chest wall, back, abdomen, flank, and groin (subcutaneous layer)
• R22.2 carries a hard Excludes1 prohibition against simultaneous use with R19.0x (internal abdominal/pelvic masses)
• The code must be replaced by a definitive diagnosis code (e.g., D17.1 for confirmed lipoma) as soon as pathology or imaging confirms the underlying condition
• Inpatient sequencing rules limit R22.2 as a principal diagnosis — use only when workup is inconclusive at discharge
• On electronic claims, submit as R222 (no decimal point) to avoid rejection
• For male breast masses, R22.2 is the appropriate holding code when N63 series is gender-contraindicated

For full coding guidance, refer to the CMS ICD-10-CM Tabular List and Official Coding Guidelines, the WHO ICD-10 online reference browser, and the AHA Coding Clinic for authoritative advisory opinions on difficult assignment scenarios.

This article is for educational purposes only and does not constitute legal, clinical, or billing advice. Always verify coding guidance against current-year CMS ICD-10-CM guidelines and consult a credentialed coding professional (CPC, CCS, RHIA) for complex coding determinations.